358 related articles for article (PubMed ID: 3883903)
1. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
[TBL] [Abstract][Full Text] [Related]
2. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
[TBL] [Abstract][Full Text] [Related]
3. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
[TBL] [Abstract][Full Text] [Related]
4. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
5. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
6. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
7. [Anticentromere antibodies. Diagnostic and prognostic value].
Meyer O; Haïm T
Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
[TBL] [Abstract][Full Text] [Related]
8. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
[TBL] [Abstract][Full Text] [Related]
9. A long-term longitudinal study of anticentromere antibodies.
Tramposch HD; Smith CD; Senecal JL; Rothfield N
Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
[TBL] [Abstract][Full Text] [Related]
10. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
11. Anticentromere antibodies--clinical correlates.
Wade JP; Sack B; Schur PH
J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
[TBL] [Abstract][Full Text] [Related]
12. [Differential diagnosis of Osler's telangiectasia and the CREST syndrome: significance of centromere antibodies].
Stolz W; Ring J; Meurer M
Hautarzt; 1988 Jun; 39(6):371-4. PubMed ID: 3403273
[TBL] [Abstract][Full Text] [Related]
13. Anticentromere antibody and primary pulmonary hypertension.
Seibold JR; Trontell MC
J Rheumatol; 1982; 9(4):607-9. PubMed ID: 6752406
[TBL] [Abstract][Full Text] [Related]
14. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.
Giordano M; Valentini G; Migliaresi S; Picillo U; Vatti M
J Rheumatol; 1986 Oct; 13(5):911-6. PubMed ID: 3546686
[TBL] [Abstract][Full Text] [Related]
15. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
Kallenberg CG; Pastoor GW; Wouda AA; The TH
Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of anticentromere antibody in blood relatives of anticentromere positive patients.
Ruffatti A; Artifoni L; Glorioso S; Calligaro A; Doria A; Gambari P; Todesco S
J Rheumatol; 1985 Oct; 12(5):940-3. PubMed ID: 3878881
[TBL] [Abstract][Full Text] [Related]
17. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
Goldman JA
Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800
[TBL] [Abstract][Full Text] [Related]
18. [Anticentromere antibodies in rheumatoid polyarthritis with Sjögren syndrome, without the elements of the CREST syndrome].
Lorcerie B; Tavernier C; Olsson O; Strauss J; Martin F
Rev Rhum Mal Osteoartic; 1988 Mar; 55(4):291-2. PubMed ID: 3259719
[No Abstract] [Full Text] [Related]
19. Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma.
Kleinsmith DM; Heinzerling RH; Burnham TK
Arch Dermatol; 1982 Nov; 118(11):882-5. PubMed ID: 6753766
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of the anticentromere antibody.
Miller MH; Littlejohn GO; Davidson A; Jones B; Topliss DJ
Br J Rheumatol; 1987 Feb; 26(1):17-21. PubMed ID: 3493051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
